Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 2Phase 3 Interventional

A Study of Brepocitinib in Adults With Cutaneous Sarcoidosis

ClinicalTrials.gov ID: NCT06978725

Public ClinicalTrials.gov record NCT06978725. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 22, 2026, 4:12 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults With Cutaneous Sarcoidosis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the clinical safety and efficacy of oral brepocitinib in participants with cutaneous sarcoidosis.

Study identification

NCT ID
NCT06978725
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Priovant Therapeutics, Inc.
Industry
Enrollment
168 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 9, 2025 (Actual)
Primary completion
Dec 31, 2028 (Estimated)
Completion
Dec 31, 2029 (Estimated)
Last update posted
Oct 21, 2026

2025 – 2029

United States locations

U.S. sites
39
U.S. states
23
U.S. cities
35
Facility City State ZIP Site status
Clinical Trial Site Birmingham Alabama 27516 Recruiting
Clinical Trial Site Phoenix Arizona 85054 Recruiting
Clinical Trial Site Tucson Arizona 85718 Recruiting
Clinical Trial Site San Francisco California 94115 Recruiting
Clinical Trial Site New Haven Connecticut 06519 Recruiting
Clinical Trial Site Washington D.C. District of Columbia 10060 Recruiting
Clinical Trial Site Atlanta Georgia 30322 Recruiting
Clinical Trial Site Sandy Springs Georgia 30328 Recruiting
Clinical Trial Site Chicago Illinois 60612 Recruiting
Clinical Trial Site Chicago Illinois 60637 Recruiting
Clinical Trial Site Kansas City Kansas 66160 Recruiting
Clinical Trial Site Louisville Kentucky 40241 Recruiting
Clinical Trial Site New Orleans Louisiana 41076 Recruiting
Clinical Trial Site Baltimore Maryland 21201 Recruiting
Clinical Trial Site Boston Massachusetts 02115 Recruiting
Clinical Trial Site Ann Arbor Michigan 48103 Recruiting
Clinical Trial Site Ann Arbor Michigan 48109 Recruiting
Clinical Trial Site Troy Michigan 48084 Recruiting
Clinical Trial Site St Louis Missouri 63110 Recruiting
Clinical Trial Site Lebanon New Hampshire 03766 Recruiting
Clinical Trial Site Brooklyn New York 11203 Recruiting
Clinical Trial Site Lake Success New York 11042 Recruiting
Clinical Trial Site New York New York 10016 Recruiting
Clinical Trial Site New York New York 10029 Recruiting
Clinical Trial Site Rochester New York 14620 Recruiting
Clinical Trial Site Chapel Hill North Carolina 27516 Recruiting
Clinical Trial Site Durham North Carolina 27703 Recruiting
Clinical Trial Site Greenville North Carolina 27834 Recruiting
Clinical Trial Site Cleveland Ohio 44195 Recruiting
Clinical Trial Site Fairborn Ohio 45324 Recruiting
Clinical Trial Site Hershey Pennsylvania 17033 Recruiting
Clinical Trial Site Philadelphia Pennsylvania 19104 Recruiting
Clinical Trial Site Philadelphia Pennsylvania 19140 Recruiting
Clinical Trial Site Charleston South Carolina 29425 Recruiting
Clinical Trial Site Houston Texas 77030 Recruiting
Clinical Trial Site Norfolk Virginia 23502 Recruiting
Clinical Trial Site Richmond Virginia 23219 Recruiting
Clinical Trial Site Madison Wisconsin 53715 Recruiting
Clinical Trial Site Milwaukee Wisconsin 53226 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06978725, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 21, 2026 · Synced Oct 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT06978725 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →